Presl, J.; Havelka, P.; Weinberger, V.; Ovesna, P.; Fekete, P.; Fruhauf, F.; Jedryka, M.; Bystricky, B.; Strojna, A.; Volodko, N.;
et al. The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study. Cancers 2024, 16, 3566.
https://doi.org/10.3390/cancers16213566
AMA Style
Presl J, Havelka P, Weinberger V, Ovesna P, Fekete P, Fruhauf F, Jedryka M, Bystricky B, Strojna A, Volodko N,
et al. The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study. Cancers. 2024; 16(21):3566.
https://doi.org/10.3390/cancers16213566
Chicago/Turabian Style
Presl, Jiri, Pavel Havelka, Vit Weinberger, Petra Ovesna, Peter Fekete, Filip Fruhauf, Marcin Jedryka, Branislav Bystricky, Aleksandra Strojna, Nataliya Volodko,
and et al. 2024. "The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study" Cancers 16, no. 21: 3566.
https://doi.org/10.3390/cancers16213566
APA Style
Presl, J., Havelka, P., Weinberger, V., Ovesna, P., Fekete, P., Fruhauf, F., Jedryka, M., Bystricky, B., Strojna, A., Volodko, N., Matylevich, O., Herboltova, P., Blecharz, P., Kalist, V., Ehrlichova, L., Stranik, P., Masak, L., Poncova, R., Czekanski, A.,
... Kostun, J.
(2024). The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—CEEGOG OX-01 Study. Cancers, 16(21), 3566.
https://doi.org/10.3390/cancers16213566
